Veterinary Medicines

Lignocaine & Adrenaline Solution for Injection

Not authorised
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride
Download as PDF

Product identification

Medicine name:
Lignocaine & Adrenaline Solution for Injection
Active substance:
  • EPINEPHRINE BITARTRATE
  • Lidocaine hydrochloride
Target species:
  • Horse
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • EPINEPHRINE BITARTRATE
    0.03
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lidocaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Meat and offal
        28
        day
  • Subcutaneous use
    • Horse
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01BB52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Lignocaine and Adrenaline Injection is marketed in 500 ml amber Type II glass vial, closed with bromobutyl rubber bung, and aluminium overseal.
  • Lignocaine and Adrenaline Injection is marketed in 100 ml amber Type II glass vial, closed with bromobutyl rubber bung, and aluminium overseal.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chem-Pharm
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10823/019/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."